Study Hypotheses Sample Clauses
Study Hypotheses. 1. Lateral VFA scans of the lumbar spine and PWV, a measurement of aortic stiffness, offer simple non-invasive methods for identifying subjects at risk of AC and subsequent CVD, which could be implemented into the clinical management of patients with OP.
2. Low BMD is associated with a greater degree of AC in postmenopausal women.
3. Bisphosphonate users have less AC compared to non-bisphosphonate users.
4. Bisphosphonates decrease AC as well as increase BMD offering an effective treatment for both OP and VC. In order to meet the research objectives as detailed in Section 2.2 the study was presented as five individual study chapters to test the study hypotheses as detailed in Section 2.3: This chapter evaluated lateral VFA imaging – primarily used for the assessment of vertebral deformity - to determine whether the method may offer a quick and reproducible method for quantifying AAC. Furthermore, this study evaluated the use of moderate dose, non-diagnostic, non-contrast CT as a reproducible alternative to higher dose diagnostic CT methods used in clinical practice to quantify VC, and also evaluated three calcium scoring methods to establish which would provide the most expedient and operator friendly method of scoring calcification using non-diagnostic CT.
Study Hypotheses. Apparently, the expiration of the lease period in Iran’s law is laid upon more robust premises and legal doctrine as compared to the laws of Egypt and France. It seems that the effects of lease period expiration in the laws of Egypt and France are more to the benefit of the landlord.
Study Hypotheses. The central aim of this study is to demonstrate that paramedic initiation of the neuroprotective agent magnesium sulfate in the field is an efficacious and safe treatment for acute stroke. The study design is a multicenter, randomized, double-blind, phase 3 clinical trial, using intention to treat analysis, of magnesium sulfate versus placebo among ambulance- transported patients with acute stroke, with study agent initiated in all individuals within two hours of stroke onset. Successful conduct of the trial will serve as a pivotal test of the promising neuroprotective agent magnesium sulfate in acute stroke, and will also demonstrate for the first time that field enrollment and treatment of acute stroke patients is a practical and feasible strategy for phase 3 stroke trials, permitting enrollment of greater numbers of patients in hyperacute time windows.